Rare diseases
Investigational molecules
Locations
Back to the Netherlands111 clinical trials in Enschede, The Netherlands across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study on Preventing Acute Kidney Injury in Cardiac Surgery Patients Using Dapagliflozin
The NetherlandsStudy on the Effects of AZD5462 for Patients with Stable Chronic Heart Failure
The NetherlandsStudy on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke
The NetherlandsStudy on Venetoclax and Azacitidine for Patients Newly Diagnosed with Higher-Risk Myelodysplastic Syndrome
The NetherlandsStudy on the Effects of Zalunfiban for Patients with ST-Elevation Myocardial Infarction (Heart Attack)
The NetherlandsStudy to Compare Mezigdomide, Carfilzomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma
The NetherlandsStudy on Atezolizumab for Patients with High-Risk Diffuse Large B-Cell Lymphoma
The NetherlandsStudy of LY3819469 for Adults with High Lipoprotein(a) Levels
The NetherlandsStudy on Aspirin for Preventing Recurrence and Improving Survival in Patients with Stage II and III Colon Cancer
The NetherlandsStudy on the Effect of DA-EPOCH-R and Nivolumab in Patients with Newly Diagnosed High-Grade B-Cell Lymphoma with MYC and BCL2/BCL6 Rearrangements
The NetherlandsStudy on Milvexian and Drug Combination for Patients Recovering from a Heart Attack
The NetherlandsStudy of Belrestotug and Dostarlimab for Patients with Untreated Advanced Non-Small Cell Lung Cancer
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on heart failure prevention and treatment of cardiovascular diseases. Studies include evaluation of new therapies for reducing cardiac events and managing arterial conditions.
Research includes novel drug combinations and preventive approaches for high-risk patients.
Comprehensive research in hematologic malignancies and solid tumors, with particular focus on innovative treatment combinations for acute myeloid leukemia and advanced cancers.
Trials evaluate targeted therapies and novel drug combinations to improve patient outcomes.
Studies addressing epileptic conditions and post-cardiac arrest neurological care, including innovative approaches to treating status epilepticus.
Focus on improving neurological outcomes in critical care settings.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
